Guoxia Technology Details Strategic Fund for New Energy Battery InvestmentsTip Ranks·Jun 18 at 08:18 AM02655+3.97%600110+1.75%
Guoxia Tech discloses fund limited partners in RMB 200 million subscription clarificationPUBT·Jun 18 at 07:39 AM02655+3.97%600110+1.75%
Lithium battery sector fluctuates and strengthens, NUODE and Jiangsu Azure Corporation hit the daily limit, Greenway rises over 10%, Great Power, Guangdong Jiayuan Technology, Defu Technology, and SDWH rise over 5%Wallstreetcn·Apr 6 at 08:50 PM688345+2.75%688388+2.90%
Effective oversight: Safety crucial for success of weight-loss drugsBusiness Standard·Mar 24 at 03:38 AM600110+1.75%NVO-9.69%
Novo Nordisk: Wegovy HD (Semaglutide 7.2 mg) has been approved in the United States. The drug has been shown to achieve a weight loss of 20.7%Wallstreetcn·Mar 19 at 10:44 AMFBT-3.47%516930+1.04%
The FDA warns that Novo Nordisk has not reported side effects or death cases related to the weight loss drug OzempicAASTOCKS·Mar 10 at 09:45 AM600110+1.75%NVO-9.69%
Novo Nordisk UBT251 shows impressive phase II clinical data in China, with a weight loss effect of nearly 20%Wallstreetcn·Feb 24 at 05:58 AM159992+1.57%516820+0.58%
"Utterly disappointed"! Deutsche Bank downgrades Novo Nordisk's rating for the first timeWallstreetcn·Feb 24 at 04:21 AM600110+1.75%
MSCI Nordic Countries Index fell 2.4%, marking the largest single-day decline since July 29, 2025, closing at 383.03 points. Among the ten sectors, the Nordic healthcare sector experienced the largest drop. The weighted stock Novo Nordisk plummeted 16.5%, performing the worst among Nordic individual stocksWallstreetcn·Feb 23 at 10:39 AMNVO-9.69%600110+1.75%
Novo Nordisk's European stock rose 8.6% after Hims & Hers Health canceled its generic Wegovy weight loss pill projectWallstreetcn·Feb 9 at 02:07 AMNVO-9.69%600110+1.75%
